# Sarah Ali

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sarah-ali/

## Facts

| Field | Value |
| --- | --- |
| Citations | 585 |
| Field | Diabetes Treatment and Management |
| h-index | 13 |
| i10-index | 15 |
| Last Known Institution | Royal Free London NHS Foundation Trust |
| OpenAlex ID | https://openalex.org/A5021916965 |
| ORCID iD | 0000-0002-3948-4917 |
| Works | 49 |

## Researcher papers

- [Diabetes in pregnancy: health risks and management](https://scholariq.org/papers/diabetes-in-pregnancy-health-risks-and-management/)
- [40th EASD Annual Meeting of the European Association for the Study of Diabetes](https://scholariq.org/papers/40th-easd-annual-meeting-of-the-european-association-for-the-study-of-diabetes/)
- [COVID-19 and disparities affecting ethnic minorities](https://scholariq.org/papers/covid-19-and-disparities-affecting-ethnic-minorities/)
- [Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States](https://scholariq.org/papers/evaluation-of-the-clinical-and-economic-burden-of-poor-glycemic-control/)
- [Cultural competence in covid-19 vaccine rollout](https://scholariq.org/papers/cultural-competence-in-covid-19-vaccine-rollout/)
- [Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis](https://scholariq.org/papers/oral-semaglutide-versus-injectable-glucagon-like-peptide-1-receptor-agonists-a/)
- [Ramadan and COVID-19 vaccine hesitancy—a call for action](https://scholariq.org/papers/ramadan-and-covid-19-vaccine-hesitancy-a-call-for-action/)
- [Hyponatremia in Association With Second-Generation Antipsychotics: A Systematic Review of Case Reports](https://scholariq.org/papers/hyponatremia-in-association-with-second-generation-antipsychotics-a-systematic/)
- [Evaluation of the Cost Per Patient Achieving Treatment Targets with Oral Semaglutide: A Short-Term Cost-Effectiveness Analysis in the United States](https://scholariq.org/papers/evaluation-of-the-cost-per-patient-achieving-treatment-targets-with-oral/)
- [Frameworks for Implementation, Uptake, and Use of Cardiometabolic Disease–Related Digital Health Interventions in Ethnic Minority Populations: Scoping Review](https://scholariq.org/papers/frameworks-for-implementation-uptake-and-use-of-cardiometabolic-disease-related/)
- [The incidence and prevalence of immunoglobulin A nephropathy in the United States](https://scholariq.org/papers/the-incidence-and-prevalence-of-immunoglobulin-a-nephropathy-in-the-united/)
- [Burden of corticosteroid therapy in patients with immunoglobulin A nephropathy (IgAN): a systematic literature review](https://scholariq.org/papers/burden-of-corticosteroid-therapy-in-patients-with-immunoglobulin-a-nephropathy/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Dietary Effects on Health](https://scholariq.org/topics/dietary-effects-on-health/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

## Researcher university

- [Royal Free London NHS Foundation Trust](https://scholariq.org/institutions/royal-free-london-nhs-foundation-trust/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.